glp 1 egfr cut off Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs Renal protection with glucagon-like peptide-1
Description
S2CID 7643584

Serious but rare side effects include pancreatitis, gallbladder problems, and allergic reactions

PLOS Glob Public Health
And people, women especially, deserve to be able to put in reasonable amounts of effort into their lifestyle, but then also see the outcome of that work

FDA approves treatment for serious liver disease known as 'MASH'
Patients with a history of chronic pancreatitis, pancreatic cancer, or other significant pancreatic disorders may not be suitable candidates for this therapy
